Trials / Sponsors / ITM Solucin GmbH
ITM Solucin GmbH
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in P Somatostatin Receptor Positive, NETs, Lymphoma | Phase 1 | 2025-09-26 |
| Active Not Recruiting | Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 Neuroendocrine Tumors | Phase 3 | 2021-12-21 |
| Active Not Recruiting | Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients Neuroendocrine Tumors | Phase 3 | 2017-02-02 |
| Available | ITM11 Expanded Access Program Meningioma | — | — |